Prescribing memantine in general practice in England: a mixed-methods study.

IF 2 Q2 PRIMARY HEALTH CARE
BJGP Open Pub Date : 2025-10-07 DOI:10.3399/BJGPO.2025.0023
Mary Carter, Joanne Butterworth, Chris Fox, Louise Allan
{"title":"Prescribing memantine in general practice in England: a mixed-methods study.","authors":"Mary Carter, Joanne Butterworth, Chris Fox, Louise Allan","doi":"10.3399/BJGPO.2025.0023","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Acetylcholinesterase inhibitors (AChEIs) are routinely prescribed for mild-to-moderate Alzheimer's disease (AD). National guidance advises GPs to initiate memantine for patients already taking an AChEI, as it offers small benefits for moderate-to-severe AD, with good tolerability. But this is not routinely done, potentially depriving patients of a beneficial treatment.</p><p><strong>Aim: </strong>To assess prescribing for AD in general practice, to explore factors influencing prescribing, and to identify additional education needs.</p><p><strong>Design & setting: </strong>Mixed-methods study involving GPs in England.</p><p><strong>Method: </strong>An online survey and semi-structured interviews were conducted. Survey responses were analysed in StataNow (version 18.5). Interview transcriptions were coded in NVivo (version 14) by two researchers, who agreed themes. Quantitative and qualitative analyses were integrated and mapped to the Theoretical Domains Framework (TDF) and behaviour change wheel (BCW).</p><p><strong>Results: </strong>Survey responders (<i>n</i> = 104) mostly continued rather than initiated memantine. Less than half were confident in identifying AD stages and developing care plans for moderate-to-severe AD. Overall, 46% of responders were unaware of current national guidance concerning memantine. Interviews (<i>n</i> = 23) mostly concurred with survey findings. Direction from local formularies conflicts with current national guidance. Mapping to TDF and BCW identified barriers to, facilitators, and interventions for changing practice.</p><p><strong>Conclusion: </strong>Limited time, patchy support, and Quality and Outcomes Framework downgrading contribute to a perception that dementia is not prioritised in general practice. Local systems for diagnosis and treatment reinforce GPs' feelings of inadequacy. GPs assess the impact of AD on patients and families but may not map assessments to a disease stage for memantine initiation. Interventions to change practice should boost knowledge and confidence; local pathways should clearly reflect national guidance.</p>","PeriodicalId":36541,"journal":{"name":"BJGP Open","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BJGP Open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3399/BJGPO.2025.0023","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PRIMARY HEALTH CARE","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Acetylcholinesterase inhibitors (AChEIs) are routinely prescribed for mild-to-moderate Alzheimer's disease (AD). National guidance advises GPs to initiate memantine for patients already taking an AChEI, as it offers small benefits for moderate-to-severe AD, with good tolerability. But this is not routinely done, potentially depriving patients of a beneficial treatment.

Aim: To assess prescribing for AD in general practice, to explore factors influencing prescribing, and to identify additional education needs.

Design & setting: Mixed-methods study involving GPs in England.

Method: An online survey and semi-structured interviews were conducted. Survey responses were analysed in StataNow (version 18.5). Interview transcriptions were coded in NVivo (version 14) by two researchers, who agreed themes. Quantitative and qualitative analyses were integrated and mapped to the Theoretical Domains Framework (TDF) and behaviour change wheel (BCW).

Results: Survey responders (n = 104) mostly continued rather than initiated memantine. Less than half were confident in identifying AD stages and developing care plans for moderate-to-severe AD. Overall, 46% of responders were unaware of current national guidance concerning memantine. Interviews (n = 23) mostly concurred with survey findings. Direction from local formularies conflicts with current national guidance. Mapping to TDF and BCW identified barriers to, facilitators, and interventions for changing practice.

Conclusion: Limited time, patchy support, and Quality and Outcomes Framework downgrading contribute to a perception that dementia is not prioritised in general practice. Local systems for diagnosis and treatment reinforce GPs' feelings of inadequacy. GPs assess the impact of AD on patients and families but may not map assessments to a disease stage for memantine initiation. Interventions to change practice should boost knowledge and confidence; local pathways should clearly reflect national guidance.

在英国的一般实践处方美金刚:一项调查和访谈研究。
背景:乙酰胆碱酯酶抑制剂(AChEIs)是轻度至中度阿尔茨海默病(AD)的常规处方。国家指南建议全科医生对已经服用乙酰氨基酚i的患者启动美金刚胺,因为它对中重度AD有很小的疗效,而且耐受性好。但这并不是常规做法,可能会剥夺患者获得有益治疗的机会。目的:评估AD的一般处方,探讨影响处方的因素,并确定额外的教育需求。设计与设置:英国全科医生参与的混合方法研究。方法:采用在线调查和半结构化访谈法。调查结果在StataNow v18.5©中进行分析。访谈记录由两位研究人员在NVivo v14©中编码,他们同意主题。定量和定性分析被整合并映射到理论领域框架(TDF)和行为改变轮(BCW)。结果:调查对象(n=115)大多继续而不是开始美金刚。不到一半的人对确定阿尔茨海默病的阶段和制定中重度阿尔茨海默病的护理计划有信心。超过40%的人不知道目前关于美金刚的国家指导。访谈(n=23)大多与调查结果一致。地方公式的指导与目前的国家指导相冲突。与TDF和BCW的映射确定了改变实践的障碍、促进因素和干预措施。结论:有限的时间,不完整的支持和QOF降级导致痴呆症在一般实践中不被优先考虑。当地的诊断和治疗系统强化了全科医生的不足感。全科医生评估AD对患者/家庭的影响,但可能不会将评估映射到疾病阶段以启动美金刚。改变实践的干预措施应该提高知识和信心;地方路径应明确反映国家指导。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BJGP Open
BJGP Open Medicine-Family Practice
CiteScore
5.00
自引率
0.00%
发文量
181
审稿时长
22 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信